Skip to content

Early Neurovascular Adaptations in Aging Women

Early Neurovascular Adaptations in Aging Women

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06520982
Enrollment
64
Registered
2024-07-25
Start date
2024-09-20
Completion date
2028-06-30
Last updated
2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women, Sympathetic Nervous System, Aging, Blood Flow

Brief summary

Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.

Interventions

DRUGNorepinephrine

Infused intra-arterially in a dose-response fashion

Infused intra-arterially in a dose-response fashion

DRUGAcetylcholine

Infused intra-arterially in a dose-response fashion

Infused intra-arterially in a dose-response fashion

DRUGEstrogen

Infused intra-arterially

Sponsors

American Heart Association (AHA)
CollaboratorUNKNOWN
University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Assigned female at birth (AFAB) * 18-70 years of age

Exclusion criteria

* Assigned male at birth (AMAB) * Pregnancy, breastfeeding * Body mass index ≥30 kg/m2 * Taking medications known to affect metabolic, autonomic, and/or respiratory function * Oral hormonal contraception in last 6 month * History of hormone replacement therapy * History of hyster- or oophor-ectomy * Current smoking/Nicotine use * Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy * Chronic disease * Blood pressure ≥140/90 mmHg * Communication barriers

Design outcomes

Primary

MeasureTime frame
Magnitude of forearm blood flowChange from baseline during infusion

Countries

United States

Contacts

Primary ContactJacqueline K Limberg
limbergj@missouri.edu573-882-2420

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026